Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-18

Clinical Trial Update: Echinaforce Junior Bioavailability Trial [Phase 4]

View source ↗

Summary

Phase 4 trial of Echinaforce Junior for the common cold was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Echinaforce Junior

Snippet

Sponsor: A. Vogel AG | Conditions: Common Cold | Phase 4 | Status: WITHDRAWN